Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Inhibition of delta-like ligand 4 decreases Th1/Th17 response in a mouse model of multiple sclerosis.
Association of methylenetetrahydrofolate reductase A1298C polymorphism but not of C677T with multiple sclerosis in Tunisian patients.
Coenzyme Q10 Supplementation Reduces Oxidative Stress and Increases Antioxidant Enzyme Activity in Patients with Relapsing-Remitting Multiple Sclerosis.
Is dosing of therapeutic immunoglobulins optimal? A review of a three-decade long debate in europe.
Lhermitte's Sign: The Current Status.
Barriers and Facilitators Related to Rehabilitation Stays in Multiple Sclerosis: A Qualitative Study.
[Characteristics of the autonomous control of cardiac activity in patients with remitting multiple sclerosis.]
Acute Disseminated Encephalomyelitis (ADEM)-A Rare Complication of Falciparum Malaria.
The use of complementary and alternative medicine in patients with multiple sclerosis: A longitudinal study.
The squares test as a measure of hand function in multiple sclerosis.
Signaling networks in MS: A systems-based approach to developing new pharmacological therapies.
Differential targeting of IL-2 and T cell receptor signaling pathways selectively expands regulatory T cells while inhibiting conventional T cells.
Management of fingolimod-associated macular edema.
Genetic aspects of vitamin D receptor and metabolism in relation to the risk of multiple sclerosis.
Pseudovirus mimics cell entry and trafficking of the human polyomavirus JCPyV.
Injury to a specific neural pathway detected by Ultra-high-field MRI.
[Acute transverse myelitis after allogeneic bone marrow transplantation for acute lymphoblastic leukemia--a case report].
Mechanisms of oligodendrocyte regeneration from ventricular-subventricular zone-derived progenitor cells in white matter diseases.
Prognostic Factors of MS Conversion in Optic Neuritis.
Immunosuppressive monoclonal antibody to CD64 from patients with long-term stable multiple sclerosis.
Pharmacodynamic Consequences of Administration of VLA-4 Antagonist CDP323 to Multiple Sclerosis Subjects: A Randomized, Double-Blind Phase 1/2 Study.
Lymphomatoid papulosis: A cutaneous lymphoproliferative disorder in a patient on fingolimod for multiple sclerosis.
How does magnetization transfer influence mcDESPOT results?
The synthetic retinoid Am80 delays recovery in a model of multiple sclerosis by modulating myeloid-derived suppressor cell fate and viability.
Teriflunomide : a novel oral treatment for relapsing multiple sclerosis.

Pages